Heritability of Magnetic Resonance Imaging (MRI) Traits in Alzheimer Disease Cases and Their Siblings in the MIRAGE Study
暂无分享,去创建一个
[1] P. Scheltens,et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[2] K. Lunetta,et al. Magnetic Resonance Imaging Traits in Siblings Discordant for Alzheimer Disease , 2008, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[3] C. Jack,et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.
[4] M. Fornage,et al. Genomic Susceptibility Loci for Brain Atrophy in Hypertensive Sibships From the GENOA Study , 2005, Hypertension.
[5] D. Harvey,et al. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.
[6] R B D'Agostino,et al. Stroke risk profile, brain volume, and cognitive function , 2004, Neurology.
[7] Charles DeCarli,et al. Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study , 2004, Stroke.
[8] Charles DeCarli,et al. Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.
[9] J. Schneider,et al. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology , 2004, Neurology.
[10] C. Jack,et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.
[11] M. Fornage,et al. Heritability of Leukoaraiosis in Hypertensive Sibships , 2004, Hypertension.
[12] Richard Mayeux,et al. The Genetics of Adult-Onset Neuropsychiatric Disease: Complexities and Conundra? , 2003, Science.
[13] John Breitner,et al. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. , 2003, Archives of neurology.
[14] V. Gallai†,et al. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. , 2003, Archives of neurology.
[15] C. DeCarli. The Role of Cerebrovascular Disease in Dementia , 2003, The neurologist.
[16] J. Schneider,et al. Relation of cerebral infarctions to dementia and cognitive function in older persons , 2003, Neurology.
[17] I. Gottesman,et al. The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.
[18] Matthijs Oudkerk,et al. Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2003, Stroke.
[19] Charles DeCarli,et al. Quantitative genetic modeling of regional brain volumes and cognitive performance in older male twins , 2002, Biological Psychology.
[20] M H Buonocore,et al. Brain structure and cognition in a community sample of elderly Latinos , 2002, Neurology.
[21] C. Jack,et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia , 2002, Neurology.
[22] R. Green,et al. Risk of dementia among white and African American relatives of patients with Alzheimer disease. , 2002, JAMA.
[23] Tyrone D. Cannon,et al. Genetic influences on brain structure , 2001, Nature Neuroscience.
[24] H. Soininen,et al. Midlife vascular risk factors and late-life mild cognitive impairment , 2001, Neurology.
[25] J Tuomilehto,et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.
[26] R. Green,et al. Reliability of Information Collected by Proxy in Family Studies of Alzheimer’s Disease , 2001, Neuroepidemiology.
[27] E. Mori,et al. Impact of White Matter Changes on Clinical Manifestation of Alzheimer’s Disease: A Quantitative Study , 2000, Stroke.
[28] C. Jack,et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.
[29] R. Killiany,et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.
[30] R. Havlik,et al. Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.
[31] P. Scheltens,et al. Apolipoprotein E ϵ4 Allele, Temporal Lobe Atrophy, and White Matter Lesions in Late-Life Dementias , 1999 .
[32] C. DeCarli,et al. Impact of Apolipoprotein E ε4 and Vascular Disease on Brain Morphology in Men From the NHLBI Twin Study , 1999 .
[33] Nick C Fox,et al. Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease , 1999, The Lancet.
[34] M N Rossor,et al. Correlation between rates of brain atrophy and cognitive decline in AD , 1999, Neurology.
[35] T. Manolio,et al. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. , 1998, Archives of neurology.
[36] B L Miller,et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. , 1998, Stroke.
[37] L. Almasy,et al. Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.
[38] E G Tangalos,et al. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease , 1998, Annals of neurology.
[39] Nick C Fox,et al. Brain atrophy progression measured from registered serial MRI: Validation and application to alzheimer's disease , 1997, Journal of magnetic resonance imaging : JMRI.
[40] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[41] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[42] Nick C. Fox,et al. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI , 1997, IEEE Transactions on Medical Imaging.
[43] C. Jack,et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.
[44] F. Fazekas,et al. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. , 1997, Stroke.
[45] Nick C Fox,et al. Visualisation and quantification of rates of atrophy in Alzheimer's disease , 1996, The Lancet.
[46] B. Lernfelt,et al. 15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.
[47] W. Tsai,et al. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. , 1996, American journal of human genetics.
[48] J. Growdon,et al. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study , 1996, Neurology.
[49] P. Scheltens,et al. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability , 1995, Journal of Neurology.
[50] Barry Horwitz,et al. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type , 1995, Psychiatry Research.
[51] S. Gauthier,et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies , 1994, Annals of neurology.
[52] J. Growdon,et al. Interrater agreement for diagnosis of Alzheimer's disease , 1994, Neurology.
[53] R. Kronmal,et al. Magnetic Resonance Abnormalities and Cardiovascular Disease in Older Adults: The Cardiovascular Health Study , 1994, Stroke.
[54] W. Burke,et al. Validation of a Telephone Version of the Mini‐Mental State Examination , 1992, Journal of the American Geriatrics Society.
[55] C. Jack,et al. MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.
[56] R B D'Agostino,et al. Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.
[57] W. Jagust,et al. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease , 1988, Magnetic resonance in medicine.
[58] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[59] H. Soininen,et al. Hypertension and Hypercholesterolaemia as Risk Factors for Alzheimer’s Disease , 2002, CNS drugs.
[60] A Pfefferbaum,et al. Heritability of hippocampal size in elderly twin men: Equivalent influence from genes and environment , 2001, Hippocampus.
[61] C. DeCarli,et al. Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. , 1999, Stroke.
[62] P. Scheltens,et al. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. , 1999, Archives of neurology.
[63] M L Bots,et al. Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study. , 1998, Journal of neural transmission. Supplementum.
[64] F Barkhof,et al. Qualitative Assessment of Cerebral Atrophy on MRI: Inter- and Intra-Observer Reproducibility in Dementia and Normal Aging , 1997, European Neurology.